Factors Influencing Pre-Hospital Delay In Patients with Acute Myocardial Infarction

Md Fakhrul Islam Khaled, S. Banerjee, D. Adhikary, M. Chowdhury, M. Mahmood, M. M. Rahman, Khurshed Ahmed, M. F. Kabir, Sanjida Ansari
{"title":"Factors Influencing Pre-Hospital Delay In Patients with Acute Myocardial Infarction","authors":"Md Fakhrul Islam Khaled, S. Banerjee, D. Adhikary, M. Chowdhury, M. Mahmood, M. M. Rahman, Khurshed Ahmed, M. F. Kabir, Sanjida Ansari","doi":"10.3329/UHJ.V15I2.42666","DOIUrl":null,"url":null,"abstract":"Acute coronary syndrome is a lethal condition. Treatment modality and success mostly depend on time yielded since onset of symptoms. It is known for more than 30 years that delay between symptom onset and treatment of less than 60 min are desirable, but pre hospital delays remain unacceptably long worldwide including Bangladesh. A greater understanding of the contributing factors may help to reduce delays. A number of sociodemographic, clinical, social and proximal factors have been associated with pre hospital delay. The total pre hospital delay period consists of two component: time taken by patients to recognize that their symptoms are serious and to contact medical help (decision time) and the time taken from requesting help to admission where emergency coronary care is available (time to hospital delay). Different factors may affect these two components. In hospital delay also known as door-to-treatment, is defined as time from arriving to hospital to initiation of reperfusion therapy. Regardless of how to shorten in hospital delay, if the pre hospital delay is not reduced, then reperfusion therapy cannot achieve the best results. We set out to discover what factors are specifically associated with three components: decision time, home to hospital delay and First Medical Contact (FMC) to revascularization delay. This review may help the National health management system to identify the factors associated with treatment delay in ACS and thus reduces ACS related morbidity and mortality. \nUniversity Heart Journal Vol. 15, No. 2, Jul 2019; 79-85","PeriodicalId":23424,"journal":{"name":"University Heart Journal","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"University Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/UHJ.V15I2.42666","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Acute coronary syndrome is a lethal condition. Treatment modality and success mostly depend on time yielded since onset of symptoms. It is known for more than 30 years that delay between symptom onset and treatment of less than 60 min are desirable, but pre hospital delays remain unacceptably long worldwide including Bangladesh. A greater understanding of the contributing factors may help to reduce delays. A number of sociodemographic, clinical, social and proximal factors have been associated with pre hospital delay. The total pre hospital delay period consists of two component: time taken by patients to recognize that their symptoms are serious and to contact medical help (decision time) and the time taken from requesting help to admission where emergency coronary care is available (time to hospital delay). Different factors may affect these two components. In hospital delay also known as door-to-treatment, is defined as time from arriving to hospital to initiation of reperfusion therapy. Regardless of how to shorten in hospital delay, if the pre hospital delay is not reduced, then reperfusion therapy cannot achieve the best results. We set out to discover what factors are specifically associated with three components: decision time, home to hospital delay and First Medical Contact (FMC) to revascularization delay. This review may help the National health management system to identify the factors associated with treatment delay in ACS and thus reduces ACS related morbidity and mortality. University Heart Journal Vol. 15, No. 2, Jul 2019; 79-85
影响急性心肌梗死患者院前延误的因素
急性冠状动脉综合征是一种致命的疾病。治疗方式和成功主要取决于症状出现后的时间。30多年来,人们都知道,从症状出现到治疗之间的延迟少于60分钟是可取的,但在包括孟加拉国在内的世界各地,院前延迟时间仍然长得令人无法接受。更好地了解造成延误的因素可能有助于减少延误。许多社会人口、临床、社会和近端因素都与院前延误有关。总住院前延迟期由两部分组成:患者认识到其症状严重并寻求医疗帮助所需的时间(决策时间),以及从请求帮助到可获得紧急冠状动脉治疗的住院所需的时间(到住院延迟时间)。不同的因素可能会影响这两个组成部分。在医院延迟也称为门到治疗,定义为从到达医院到开始再灌注治疗的时间。无论如何缩短院前延迟,如果不减少院前延迟,那么再灌注治疗就无法达到最佳效果。我们着手发现哪些因素与三个组成部分具体相关:决策时间、从家到医院的延迟和首次医疗接触(FMC)到血运重建的延迟。本综述可能有助于国家卫生管理系统识别与ACS治疗延迟相关的因素,从而降低ACS相关的发病率和死亡率。《大学心脏杂志》2019年7月第15卷第2期;79 - 85
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信